MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Investor.neurometrix.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Investor.neurometrix.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Investor.neurometrix.com most likely does not offer any adult content.
Popular pages
-
Stock Information | NeuroMetrix
The Investor Relations website contains information about NeuroMetrix 's business for stockholders, potential investors, and financial analysts.
-
NeuroMetrix Reports Q4 and Full Year 2022 Financial Results | NeuroMetrix
Feb. 23, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2022. The Company's mission is ...
-
NeuroMetrix Reports Q4 and Full Year 2021 Financial Results | NeuroMetrix
$8.3 million increased by 11.9% from the prior year. DPNCheck ® sales into Medicare Advantage was the primary contributor to revenue. On a full year basis, it posted revenue growth of 26.0% Q4 gross m...
-
Press Releases | NeuroMetrix
WOBURN, Mass. , July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening o...
-
NeuroMetrix Reports Q1 2023 Financial Results | NeuroMetrix
$2.3M in the first quarter of 2022. The primary reason was that DPNCheck ® sales declined due to a suspension of screening programs, including DPNCheck, by the Company’s largest Medicare Advantage cus...
-
NeuroMetrix Reports Q2 2022 Financial Results | NeuroMetrix
July 21, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and six months period ended June 30, 2022. The Company's mission...